FREE patent keyword monitoring and additional FREE benefits. http://images1.freshpatents.com/images/triangleright (1K) REGISTER now for FREE triangleleft (1K)
FreshPatents.com Logo    FreshPatents.com icons
Monitor Keywords Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents

Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |

Astrazeneca R&d Boston patents

The following is a sampling of recent Astrazeneca R&d Boston patent applications (USPTO Patent Application #, Patent Title) sorted by month.

February 2011 - Astrazeneca R&d Boston patents

20110046108 - Pyrimidine derivatives
20110034454 - Morpholino pyrimidine derivatives and their use in therapy
20110028471 - Combination therapy 238
20110028498 - Method for evaluating patients for treatment with drugs targeting ret receptor tyrosine kinase

January 2011 - Astrazeneca R&d Boston patents

20110015392 - Process for preparing pyridone derivatives 226
20110009373 - Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis
20110003831 - N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent

December 2010 - Astrazeneca R&d Boston patents

20100331329 - Benzamide derivatives useful as histone deacetylase inhibitors
20100324040 - 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyrazol-3-yl) -3h-imidazo[4,5-b] pyridin-5- amine derivatives and their use for the treatment of cancer
20100317593 - 2,3-dihydro-1h-indene compounds
20100317624 - Heterocyclic urea derivatives and methods of use thereof
20100311748 - Heterocyclic amides useful for the treatment of cancer and psoriasis

November 2010 - Astrazeneca R&d Boston patents

20100292222 - Chemical compounds 751
20100286181 - Pyrrole derivatives with antibacterial activity
20100278835 - Novel compounds 660
20100280048 - Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase

October 2010 - Astrazeneca R&d Boston patents

20100273811 - N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
20100267699 - Chemical compounds - 643
20100261690 - Novel combinations
20100261719 - Chemical compounds
20100261723 - Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
20100256103 - Novel compounds
20100256105 - Novel compounds

September 2010 - Astrazeneca R&d Boston patents

20100249112 - Combination of chk and parp inhibitors for the treatment of cancers
20100249131 - Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
20100240645 - Combination of checkponit kinase (chk) and telangiectasia mutated (atm) inhibitors for the treatment of cancer
20100240686 - Chemical compounds
20100226917 - Methods for the treatment of hematologic malignancies
20100227858 - Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
20100222344 - 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors

August 2010 - Astrazeneca R&d Boston patents

20100210648 - Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
20100204231 - Amino-thiazolyl-pyrimidine derivatives and their use for the treatment of cancer
20100204246 - 5-aminopyrazol-3-yl-3h-imidazo (4,5-b) pyridine derivatives and their use for the treatment of cancer
20100197749 - Chemical compounds

July 2010 - Astrazeneca R&d Boston patents

20100190745 - Heterocyclic urea derivatives and methods of use thereof
20100179150 - Antibacterial piperdine derivatives
20100179161 - Pyrazoline derivatives for the treatment of turberculosis
20100173909 - Piperidine compounds and uses thereof - 596
20100168143 - Quinazoline derivatives

June 2010 - Astrazeneca R&d Boston patents

20100158863 - Triazoloanilinopyrimidine derivatives for use as antiviral agents
20100160325 - 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
20100160627 - Novel lactams and uses thereof
20100152169 - 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases
20100152219 - Pyrazole derivatives as inhibitors of receptor tyrosine kinases
20100152441 - Compounds for the treatment of multi-drug resistant bacterial infections
20100144717 - 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
20100144759 - Novel n-(fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor ccr4
20100137303 - New compound 255
20100137304 - Novel crystalline forms of the anti-cancer compound zd1839
20100137313 - Heterocyclic derivatives and methods of use thereof
20100137397 - Chemical compounds

April 2010 - Astrazeneca R&d Boston patents

20100105655 - Novel compounds 515
20100098763 - Pharmaceutical formulation 514
20100094010 - Chemical process
20100086942 - Compounds

March 2010 - Astrazeneca R&d Boston patents

20100075942 - N-phenyl-4-pyridin-2-yl-benzamide derivatives as histone deacylase (hdac) inhibitors for the treatment of cancer
20100069412 - Phosphonoxy quinazoline derivatives and their pharmaceutical use

February 2010 - Astrazeneca R&d Boston patents

20100048543 - Pyrimidine compounds having ties (tek) inhibitory activity
20100041912 - Method for the wittig reaction in the preparation of carboprost
20100035896 - Combination of n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic cytotoxic agent
20100029643 - Heterocyclyc sulfonamides having edg-1 antagonistic activity

January 2010 - Astrazeneca R&d Boston patents

20100022476 - Pyrazolylamino substituted quinazoles for the treatment of cancer
20100022534 - 2-benzimidazolyl-6-morpholino-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
20100016279 - Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155
20100004181 - Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-(1,3,4-oxadiazol-2-yl)phenyl) pyridine-3-sulphonamide and an lhrh analogue and/or a bisphosphonate
20100004247 - Combination comprising a mek inhibitor and an aurora kinase inhibitor 188

December 2009 - Astrazeneca R&d Boston patents

20090324601 - Targeted binding agents directed to pdgfr-alpha and uses thereof
20090325902 - Heterocyclic urea derivatives and methods of use thereof
20090325954 - 2-benzimidazolyl-6-morpholino-4-phenylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
20090318427 - Benzodiazepine derivatives for treating hepatitis c infection
20090318468 - Pyrazole compounds 436
20090312396 - Methods for cancer treatment using tak1 inhibitors
20090312336 - Dihydropteridine compounds as anti proliferative agents
20090312556 - N-(2-aminiphenyl)-4-(5-((ethylamino)methyl)-1,2-thiazol-2-yl) benzamide and n-(2-aminophenyl)-4-(5-((isopropylamino)methyl)-1,2-thiazol-2-yl) benzamide as hdac inhibitors
20090306116 - Pyrimidine derivatives for the inhibition of igf-ir tyrosine kinase activity

November 2009 - Astrazeneca R&d Boston patents

20090291961 - Combination of an mek inhibitor and the src kinase inhibitor azd0530 for use in the treatment of cancer
20090286982 - Novel salt-554
20090275570 - Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
20090275570 - Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Astrazeneca R&d Boston in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Astrazeneca R&d Boston with additional patents listed. Browse our Agent directory for other possible listings. Advertise on FreshPatents.com - Rates & Info

###

FreshPatents.com Support - Terms & Conditions